lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
Melanoma is the most lethal skin cancer with increasing incidence worldwide. Despite a great improvement of diagnostics and treatment of melanoma patients, this disease is still a serious clinical problem. Therefore, novel druggable targets are in focus of research. EZH2 is a component of the PRC2 p...
Main Authors: | Michal Wozniak, Malgorzata Czyz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1170026/full |
Similar Items
-
The combined use of long non-coding RNA HOTAIR and polycomb group protein EZH2 as a prognostic marker of lung adenocarcinoma
by: Toshihiko Iizuka, et al.
Published: (2022-01-01) -
The role of lncRNAs and exosomal lncRNAs in cancer metastasis
by: Yutong Zhang, et al.
Published: (2023-09-01) -
LncRNAs in Cancer: From garbage to Junk
by: Marianna Aprile, et al.
Published: (2020-10-01) -
The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
by: Wencheng Zhou, et al.
Published: (2022-12-01) -
LncRNAs and PRC2: Coupled Partners in Embryonic Stem Cells
by: Alessandro Fiorenzano, et al.
Published: (2019-08-01)